Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-04-24

Clinical Trial Update: A Comparison of Long-acting Injectable Medications for Schizophrenia [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update comparing long-acting injectable antipsychotics for schizophrenia and schizoaffective disorder; results were posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: New York State Psychiatric Institute | Conditions: Schizophrenia, Schizoaffective Disorder | Phase 4 | Status: COMPLETED | Results posted: 2015-04-24